Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis
{{output}}
Background: Extended interval dosing (EID) of natalizumab is increasingly used in clinical practice for patients with multiple sclerosis, driven by growing evidence supporting its sustained efficacy and associated benefits. Howev... ...
